quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:08:07·154d
ANALYSTRating
OPKO Health Inc. logo

Analyst initiated coverage on Opko Health

OPK· OPKO Health Inc.
Health Care
Original source

Companies

  • OPK
    OPKO Health Inc.
    Health Care

Recent analyst ratings

  • Nov 20UpdateAnalyst-
  • Oct 31UpdateJefferies$1.60
  • Apr 25UpdateAnalyst-
  • Jun 29UpdateBarrington Research$2.00
  • Dec 15UpdateH.C. Wainwright$3.00
  • Jan 24UpdateBarrington Research-

Related

  • PR1d
    OPKO Health's ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas
  • PR2d
    OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026
  • PR15d
    OPKO Health's ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19
  • INSIDER34d
    SEC Form 4 filed by Paganelli John A
  • INSIDER34d
    SEC Form 4 filed by Uppaluri Subbarao V
  • INSIDER34d
    SEC Form 3 filed by new insider Uppaluri Subbarao V
  • SEC35d
    OPKO Health Inc. filed SEC Form 8-K: Leadership Update
  • PR55d
    OPKO Health to Participate in the Jefferies Biotech on the Beach Summit
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022